190 related articles for article (PubMed ID: 32250211)
1. Drug Delivery Systems Using Surface Markers for Targeting Cancer Stem Cells.
Oswald JT; Patel H; Khan D; Jeorje NN; Golzar H; Oswald EL; Tang S
Curr Pharm Des; 2020; 26(17):2057-2071. PubMed ID: 32250211
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
3. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells.
Li L; Ni R; Zheng D; Chen L
Daru; 2023 Jun; 31(1):83-94. PubMed ID: 36971921
[TBL] [Abstract][Full Text] [Related]
4. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
5. Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.
Krishnamurthy S; Ke X; Yang YY
Nanomedicine (Lond); 2015 Jan; 10(1):143-60. PubMed ID: 25597774
[TBL] [Abstract][Full Text] [Related]
6. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells.
Zhang Z; Deng Q; Xiao C; Li Z; Yang X
Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.
Gao J; Li W; Guo Y; Feng SS
Nanomedicine (Lond); 2016 Dec; 11(24):3261-3282. PubMed ID: 27854161
[TBL] [Abstract][Full Text] [Related]
8. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine-mediated drug targeting of cancer stem cells.
Singh D; Minz AP; Sahoo SK
Drug Discov Today; 2017 Jun; 22(6):952-959. PubMed ID: 28435061
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells and drug resistance: the potential of nanomedicine.
Vinogradov S; Wei X
Nanomedicine (Lond); 2012 Apr; 7(4):597-615. PubMed ID: 22471722
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells and strategies for targeted drug delivery.
Cao J; Bhatnagar S; Wang J; Qi X; Prabha S; Panyam J
Drug Deliv Transl Res; 2021 Oct; 11(5):1779-1805. PubMed ID: 33095384
[TBL] [Abstract][Full Text] [Related]
14. Nucleus-targeted nano delivery system eradicates cancer stem cells by combined thermotherapy and hypoxia-activated chemotherapy.
Li H; Yan W; Suo X; Peng H; Yang X; Li Z; Zhang J; Liu D
Biomaterials; 2019 Apr; 200():1-14. PubMed ID: 30743049
[TBL] [Abstract][Full Text] [Related]
15. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
Kim SS; Harford JB; Pirollo KF; Chang EH
Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
17. Multimodal Nanomedicine Strategies for Targeting Cancer Cells as well as Cancer Stem Cell Signalling Mechanisms.
Kanwar JR; Samarasinghe RM; Kamalapuram SK; Kanwar RK
Mini Rev Med Chem; 2017; 17(18):1688-1695. PubMed ID: 26891936
[TBL] [Abstract][Full Text] [Related]
18. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; PĆ¼tzer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells.
Sun R; Shen S; Zhang YJ; Xu CF; Cao ZT; Wen LP; Wang J
Biomaterials; 2016 Oct; 103():44-55. PubMed ID: 27376558
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]